Analyst Ratings for AstraZeneca PLC ADR (AZN)

Updated: 2017-07-26

An average rating of Overweight has been given to AstraZeneca PLC ADR (NYSE:AZN) by analysts covering the stock. A consensus rating of Overweight was previously issued for AZN last month.

18 analysts declared AZN a buy, 2 gave an overweight rating, 14 gave a hold rating, 1 gave an underweight rating, and 4 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 2. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Investment analysts gave a few price targets for AZN. The maximum price target given was 51.55, implying potential capital gains of 52.74 percent. The most pessimistic price target was 25, which equates to a potential downside of -25.93 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of -5.73 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -4.6 percent. Meanwhile, fiscal year estimates have been revised downwards by -0.54 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.1 percent.

People are often interested in whether analysts were united in the direction of their revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 2 analysts revised their estimates downwards. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 3 analysts decreased their estimates.

Analysts estimate earnings of AZN to grow at a rate of 50.63 percent. The PEG ratio of a stock is another value frequently studied by investors. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. PEG ratios below 1 are often considered desirable, but many choose to perform ratio comparisons with other companies in the industry. AZN has a PEG ratio of 0.55.

In the trailing 52-weeks, AZN hit 35.60 at the highest peak, while it's lowest trading point was 25.55. Today's price is 32.09 percent above the 52-week low, and 5.2 percent lower than its 52-week high. AZN has a price/earnings ratio of 27.61. Investors typically compare the P/E ratio to a company's peers in the industry. The AZN value stock report compares AZN to some of its peers using value stock charts. The stock has a market capitalization of $84.02 billion. AZN's next earnings release will be on 0000-00-00, which is days away.